Alnylam Pharmaceuticals (ALNY) Intangibles (2009 - 2012)

Alnylam Pharmaceuticals (ALNY) has 4 years of Intangibles data on file, last reported at $145000.0 in Q3 2012.

• Quarterly Intangibles fell 54.4% year-over-year to $145000.0 in Q3 2012, while the trailing twelve-month figure through Sep 2012 was $145000.0 (down 54.4% YoY) and the FY2011 annual result came in at $275000.0, down 38.62% from the prior year.
• Intangibles fell to $145000.0 in Q3 2012, from $188000.0 in the prior quarter.
• In the past five years, Intangibles ranged from a high of $622000.0 in Q4 2009 to a low of $145000.0 in Q3 2012.
• A 4-year average of $365363.6 and a median of $361000.0 in 2011 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2010 — Intangibles decreased 27.97% — and 2012, when it plunged 54.4%.
• Tracing ALNY's Intangibles over 4 years: stood at $622000.0 in 2009, then declined by 27.97% to $448000.0 in 2010, then sank by 38.62% to $275000.0 in 2011, then slumped by 47.27% to $145000.0 in 2012.
• The last three Intangibles figures came in at $145000.0 (Q3 2012), $188000.0 (Q2 2012), and $231000.0 (Q1 2012), per Business Quant data.